IP Library Patent Application 16890674
Patent Application
App. No. 16/890,674

Antiviral Face Mask

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/890,674
Abstract

Disclosed herein are washable, reusable, antimicrobial and antiviral face masks and methods of their use for the reduction of transmission of infectious pathogens. Exemplary face masks are made of silver-coated material wherein activation of the silver from moisture in a user's breath kills pathogens. The disclosed face masks are useful in reducing, inhibiting or killing pathogens, such as SARS-CoV-2, that contact the face mask within 2 hours of continuous contact.

Claims (24)

1 . An antimicrobial and antiviral face mask comprising,

a mask body comprising at least one layer of a silver-coated material, wherein the mask body is shaped such that it covers at least the mouth and nose of a subject, and

a means to affix the face mask to the subject's face, wherein the means to affix the face mask to the subject's face is connected to the body of the mask.

2 . The face mask of claim 1 , wherein the silver-coated material is a fabric comprising woven silver-plated porous nylon.

3 . The face mask of claim 2 , wherein the silver-plated porous nylon is plated with 90% to 99% silver and 1% to 10% silver oxide.

4 . The face mask of claim 1 , wherein the means to affix the face mask to a subject's face comprise ear loops.

5 . The face mask of claim 1 , wherein the means to affix the face mask to a subject's face comprise tie straps.

6 . The face mask of claim 1 , wherein the body further comprises additional layers.

7 . The face mask of claim 6 , wherein the additional layer comprises a filter layer.

8 . The face mask of claim 7 , wherein the filter layer is a hepafilter.

9 . The face mask of claim 1 , further comprising a pocket for a hepafilter.

10 . The face mask of claim 9 , wherein the pocket is between two layers of silver-coated material.

11 . The face mask of claim 6 , wherein the additional layer is a non-silver-coated fabric layer on the side of the face mask body that contacts the subject's face.

12 . The face mask of claim 1 , wherein the face mask body comprises two layers of silver-coated material.

13 . The face mask of claim 1 , wherein the body comprises a single piece of silver-coated material, and the means to affix the mask to the subject's face comprise ear loops cut from the body material.

14 . The face mask of claim 1 , wherein the body comprises more than one piece of fabric held together with nylon thread.

15 . The face mask of claim 1 , wherein the silver is activated by moisture and kills viruses and microbes that contact the mask.

16 . An antiviral and antimicrobial face mask, comprising,

at least one layer of a silver-coated fabric, wherein the silver-coated fabric comprises woven porous nylon plated with 90% to 99% silver and 1% to 10% silver oxide, and wherein the fabric comprises ear loops cut from the fabric.

17 . A method of reducing viral transmission to a subject, comprising, affixing to the face of the subject the face mask of claim 1 , wherein activation of the silver by moisture from the subject's breath inactivates, kills, or reduces virus particles that remain in contact with the face mask

18 . The method of claim 16 , wherein the virus particles are inactivated, killed, or reduced within 2 hours of continuous contact.

19 . The method of claim 16 , wherein the virus particles are inactivated, killed, or reduced within 1 hour of contact.

20 . The method of claim 16 , wherein the virus is SARS-CoV-2 virus.

21 . The method of claim 20 , wherein the SARS-CoV-2 virus is inactivated by a 5-log reduction within two hours of continuous contact.

Assignments (2)
SECURITY INTEREST Recorded Jan 31, 2023
From: BIODERM, INC.; ARGENTUM MEDICAL, LLC
To: OXFORD FINANCE LLC, AS AGENT
Reel/Frame 062550/0047 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2020
From: BRIZUELA, RAUL
To: ARGENTUM MEDICAL, LLC
Reel/Frame 053987/0595 →